iRhythm Data at ACC.26 Shows High Arrhythmia Prevalence in CKM Patients
Event summary
- iRhythm presented data at ACC.26 showing high prevalence of clinically actionable arrhythmias in patients across the cardiovascular-kidney-metabolic (CKM) continuum using its Zio® ambulatory ECG portfolio.
- Chief Medical Officer Mintu Turakhia delivered the 57th Annual Louis F. Bishop Keynote on scaling AI in cardiology at ACC.26.
- iRhythm launched iRhythm Academy, a digital education platform for clinicians focused on ambulatory cardiac monitoring.
The big picture
iRhythm’s ACC.26 data reinforces the growing evidence supporting early arrhythmia detection in high-risk cardiometabolic patients, aligning with broader industry shifts toward predictive and preventive cardiac care. The launch of iRhythm Academy underscores the company’s push to educate clinicians at scale, a critical factor as AI and digital health tools become more integrated into routine cardiovascular practice.
What we're watching
- Diagnostic Expansion
- How iRhythm’s data will influence adoption of proactive cardiac monitoring in high-risk CKM populations.
- AI Integration
- Whether iRhythm can sustain leadership in AI-driven cardiology as the field scales.
- Educational Impact
- The pace at which iRhythm Academy accelerates clinician proficiency in ambulatory cardiac monitoring.
Related topics